[Federal Register Volume 67, Number 156 (Tuesday, August 13, 2002)]
[Notices]
[Page 52733]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4), and 552b(6), as 
amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Dates: September 9-10, 2002.
    Open: September 9, 2002, 8:30 a.m. to 4 p.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: September 9, 2002, 4 p.m. to Recess.
    Agenda: Review of grant applications; Discussion of confidential 
personnel issues.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Open: September 10, 2002, 8:45 a.m. to 11:45 p.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin Kalt, Executive Secretary, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, (301) 496-
5147.

    An interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government employees. 
Persons without a government I.D. will need to show a photo I.D. and 
sign-in at the security desk upon entering the building.
    Information is also available on the Institute's/Center's Home 
Page: http://deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.


(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control; National Institutes of Health, HHS)

    Dated: August 6, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-20420 Filed 8-12-02; 8:45 am]
BILLING CODE 4140-01-M